Koshinski Asset Management Inc. Has $1.74 Million Stake in Aflac Incorporated (NYSE:AFL)

Koshinski Asset Management Inc. lifted its position in shares of Aflac Incorporated (NYSE:AFL) by 34.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,824 shares of the financial services provider’s stock after buying an additional 4,336 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Aflac were worth $1,740,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Renaissance Technologies LLC bought a new position in shares of Aflac in the 2nd quarter worth about $10,878,000. Beck Bode LLC increased its holdings in Aflac by 1.3% in the second quarter. Beck Bode LLC now owns 143,350 shares of the financial services provider’s stock worth $12,803,000 after purchasing an additional 1,857 shares in the last quarter. Ieq Capital LLC lifted its stake in Aflac by 0.5% in the second quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider’s stock valued at $1,945,000 after buying an additional 101 shares during the period. King Luther Capital Management Corp boosted its holdings in shares of Aflac by 30.7% during the 2nd quarter. King Luther Capital Management Corp now owns 3,600 shares of the financial services provider’s stock worth $322,000 after buying an additional 846 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its position in shares of Aflac by 7.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 28,727 shares of the financial services provider’s stock worth $2,566,000 after buying an additional 2,051 shares during the period. Institutional investors own 67.44% of the company’s stock.

Insiders Place Their Bets

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.80% of the company’s stock.

Aflac Price Performance

Shares of NYSE AFL opened at $106.43 on Tuesday. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $59.13 billion, a PE ratio of 16.03, a PEG ratio of 2.09 and a beta of 1.00. The stock’s 50 day moving average price is $106.41 and its 200-day moving average price is $105.47. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion for the quarter, compared to analysts’ expectations of $4.30 billion. During the same quarter in the previous year, the firm earned $1.84 earnings per share. The business’s revenue was down 40.4% on a year-over-year basis. On average, equities analysts anticipate that Aflac Incorporated will post 7.26 EPS for the current year.

Aflac Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date is Wednesday, February 19th. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio (DPR) is 30.12%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of Aflac from $103.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 14th. Piper Sandler increased their price objective on shares of Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Wednesday, January 8th. Keefe, Bruyette & Woods dropped their price target on Aflac from $108.00 to $107.00 and set a “market perform” rating on the stock in a research note on Friday, January 10th. Finally, Truist Financial raised their price objective on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $102.07.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.